img

Global Orexin Receptor Type 2 Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Orexin Receptor Type 2 Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Orexin Receptor Type 2 report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Orexin Receptor Type 2 market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Insomnia and Narcolepsy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Orexin Receptor Type 2 industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Orexin Receptor Type 2 key companies include Actelion Pharmaceuticals Ltd, Eisai Co Ltd, Evotec AG, Heptares Therapeutics Ltd, Idorsia Ltd, Johnson & Johnson, Merck & Co Inc, OptiNose US Inc and Yangtze River Pharmaceutical Group, etc. Actelion Pharmaceuticals Ltd, Eisai Co Ltd, Evotec AG are top 3 players and held % share in total in 2022.
Orexin Receptor Type 2 can be divided into HTL-6641, MK-8133, Lemborexant and OPN-021, etc. HTL-6641 is the mainstream product in the market, accounting for % share globally in 2022.
Orexin Receptor Type 2 is widely used in various fields, such as Insomnia, Narcolepsy, Sleep Disorders and Major Depressive Disorder, etc. Insomnia provides greatest supports to the Orexin Receptor Type 2 industry development. In 2022, global % share of Orexin Receptor Type 2 went into Insomnia filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Orexin Receptor Type 2 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Actelion Pharmaceuticals Ltd
Eisai Co Ltd
Evotec AG
Heptares Therapeutics Ltd
Idorsia Ltd
Johnson & Johnson
Merck & Co Inc
OptiNose US Inc
Yangtze River Pharmaceutical Group
Segment by Type
HTL-6641
MK-8133
Lemborexant
OPN-021
YNT-185
Others

Segment by Application


Insomnia
Narcolepsy
Sleep Disorders
Major Depressive Disorder
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Orexin Receptor Type 2 market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Orexin Receptor Type 2 introduction, etc. Orexin Receptor Type 2 Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Orexin Receptor Type 2 market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Market Overview of Orexin Receptor Type 2
1.1 Orexin Receptor Type 2 Market Overview
1.1.1 Orexin Receptor Type 2 Product Scope
1.1.2 Orexin Receptor Type 2 Market Status and Outlook
1.2 Global Orexin Receptor Type 2 Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global Orexin Receptor Type 2 Market Size by Region (2018-2034)
1.4 Global Orexin Receptor Type 2 Historic Market Size by Region (2018-2024)
1.5 Global Orexin Receptor Type 2 Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Orexin Receptor Type 2 Market Size (2018-2034)
1.6.1 North America Orexin Receptor Type 2 Market Size (2018-2034)
1.6.2 Europe Orexin Receptor Type 2 Market Size (2018-2034)
1.6.3 Asia-Pacific Orexin Receptor Type 2 Market Size (2018-2034)
1.6.4 Latin America Orexin Receptor Type 2 Market Size (2018-2034)
1.6.5 Middle East & Africa Orexin Receptor Type 2 Market Size (2018-2034)
2 Orexin Receptor Type 2 Market by Type
2.1 Introduction
2.1.1 HTL-6641
2.1.2 MK-8133
2.1.3 Lemborexant
2.1.4 OPN-021
2.1.5 YNT-185
2.1.6 Others
2.2 Global Orexin Receptor Type 2 Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global Orexin Receptor Type 2 Historic Market Size by Type (2018-2024)
2.2.2 Global Orexin Receptor Type 2 Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Orexin Receptor Type 2 Revenue Breakdown by Type (2018-2034)
2.3.2 Europe Orexin Receptor Type 2 Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific Orexin Receptor Type 2 Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America Orexin Receptor Type 2 Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa Orexin Receptor Type 2 Revenue Breakdown by Type (2018-2034)
3 Orexin Receptor Type 2 Market Overview by Application
3.1 Introduction
3.1.1 Insomnia
3.1.2 Narcolepsy
3.1.3 Sleep Disorders
3.1.4 Major Depressive Disorder
3.2 Global Orexin Receptor Type 2 Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global Orexin Receptor Type 2 Historic Market Size by Application (2018-2024)
3.2.2 Global Orexin Receptor Type 2 Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Orexin Receptor Type 2 Revenue Breakdown by Application (2018-2034)
3.3.2 Europe Orexin Receptor Type 2 Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific Orexin Receptor Type 2 Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America Orexin Receptor Type 2 Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa Orexin Receptor Type 2 Revenue Breakdown by Application (2018-2034)
4 Orexin Receptor Type 2 Competition Analysis by Players
4.1 Global Orexin Receptor Type 2 Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Orexin Receptor Type 2 as of 2022)
4.3 Date of Key Players Enter into Orexin Receptor Type 2 Market
4.4 Global Top Players Orexin Receptor Type 2 Headquarters and Area Served
4.5 Key Players Orexin Receptor Type 2 Product Solution and Service
4.6 Competitive Status
4.6.1 Orexin Receptor Type 2 Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Actelion Pharmaceuticals Ltd
5.1.1 Actelion Pharmaceuticals Ltd Profile
5.1.2 Actelion Pharmaceuticals Ltd Main Business
5.1.3 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Products, Services and Solutions
5.1.4 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Revenue (US$ Million) & (2018-2024)
5.1.5 Actelion Pharmaceuticals Ltd Recent Developments
5.2 Eisai Co Ltd
5.2.1 Eisai Co Ltd Profile
5.2.2 Eisai Co Ltd Main Business
5.2.3 Eisai Co Ltd Orexin Receptor Type 2 Products, Services and Solutions
5.2.4 Eisai Co Ltd Orexin Receptor Type 2 Revenue (US$ Million) & (2018-2024)
5.2.5 Eisai Co Ltd Recent Developments
5.3 Evotec AG
5.3.1 Evotec AG Profile
5.3.2 Evotec AG Main Business
5.3.3 Evotec AG Orexin Receptor Type 2 Products, Services and Solutions
5.3.4 Evotec AG Orexin Receptor Type 2 Revenue (US$ Million) & (2018-2024)
5.3.5 Heptares Therapeutics Ltd Recent Developments
5.4 Heptares Therapeutics Ltd
5.4.1 Heptares Therapeutics Ltd Profile
5.4.2 Heptares Therapeutics Ltd Main Business
5.4.3 Heptares Therapeutics Ltd Orexin Receptor Type 2 Products, Services and Solutions
5.4.4 Heptares Therapeutics Ltd Orexin Receptor Type 2 Revenue (US$ Million) & (2018-2024)
5.4.5 Heptares Therapeutics Ltd Recent Developments
5.5 Idorsia Ltd
5.5.1 Idorsia Ltd Profile
5.5.2 Idorsia Ltd Main Business
5.5.3 Idorsia Ltd Orexin Receptor Type 2 Products, Services and Solutions
5.5.4 Idorsia Ltd Orexin Receptor Type 2 Revenue (US$ Million) & (2018-2024)
5.5.5 Idorsia Ltd Recent Developments
5.6 Johnson & Johnson
5.6.1 Johnson & Johnson Profile
5.6.2 Johnson & Johnson Main Business
5.6.3 Johnson & Johnson Orexin Receptor Type 2 Products, Services and Solutions
5.6.4 Johnson & Johnson Orexin Receptor Type 2 Revenue (US$ Million) & (2018-2024)
5.6.5 Johnson & Johnson Recent Developments
5.7 Merck & Co Inc
5.7.1 Merck & Co Inc Profile
5.7.2 Merck & Co Inc Main Business
5.7.3 Merck & Co Inc Orexin Receptor Type 2 Products, Services and Solutions
5.7.4 Merck & Co Inc Orexin Receptor Type 2 Revenue (US$ Million) & (2018-2024)
5.7.5 Merck & Co Inc Recent Developments
5.8 OptiNose US Inc
5.8.1 OptiNose US Inc Profile
5.8.2 OptiNose US Inc Main Business
5.8.3 OptiNose US Inc Orexin Receptor Type 2 Products, Services and Solutions
5.8.4 OptiNose US Inc Orexin Receptor Type 2 Revenue (US$ Million) & (2018-2024)
5.8.5 OptiNose US Inc Recent Developments
5.9 Yangtze River Pharmaceutical Group
5.9.1 Yangtze River Pharmaceutical Group Profile
5.9.2 Yangtze River Pharmaceutical Group Main Business
5.9.3 Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Products, Services and Solutions
5.9.4 Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Revenue (US$ Million) & (2018-2024)
5.9.5 Yangtze River Pharmaceutical Group Recent Developments
6 North America
6.1 North America Orexin Receptor Type 2 Market Size by Country (2018-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Orexin Receptor Type 2 Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Orexin Receptor Type 2 Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Orexin Receptor Type 2 Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Orexin Receptor Type 2 Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Orexin Receptor Type 2 Market Dynamics
11.1 Orexin Receptor Type 2 Industry Trends
11.2 Orexin Receptor Type 2 Market Drivers
11.3 Orexin Receptor Type 2 Market Challenges
11.4 Orexin Receptor Type 2 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Orexin Receptor Type 2 Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global Orexin Receptor Type 2 Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Orexin Receptor Type 2 Market Size Share by Region (2018-2024)
Table 4. Global Orexin Receptor Type 2 Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Orexin Receptor Type 2 Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Orexin Receptor Type 2 Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global Orexin Receptor Type 2 Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Orexin Receptor Type 2 Revenue Market Share by Type (2018-2024)
Table 9. Global Orexin Receptor Type 2 Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Orexin Receptor Type 2 Revenue Market Share by Type (2024-2034)
Table 11. North America Orexin Receptor Type 2 Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Orexin Receptor Type 2 Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Orexin Receptor Type 2 Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Orexin Receptor Type 2 Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Orexin Receptor Type 2 Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Orexin Receptor Type 2 Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Orexin Receptor Type 2 Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Orexin Receptor Type 2 Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Orexin Receptor Type 2 Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Orexin Receptor Type 2 Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Orexin Receptor Type 2 Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global Orexin Receptor Type 2 Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Orexin Receptor Type 2 Revenue Market Share by Application (2018-2024)
Table 24. Global Orexin Receptor Type 2 Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Orexin Receptor Type 2 Revenue Market Share by Application (2024-2034)
Table 26. North America Orexin Receptor Type 2 Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Orexin Receptor Type 2 Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Orexin Receptor Type 2 Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Orexin Receptor Type 2 Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Orexin Receptor Type 2 Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Orexin Receptor Type 2 Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Orexin Receptor Type 2 Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Orexin Receptor Type 2 Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Orexin Receptor Type 2 Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Orexin Receptor Type 2 Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Orexin Receptor Type 2 Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Orexin Receptor Type 2 Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Orexin Receptor Type 2 as of 2022)
Table 39. Date of Key Players Enter into Orexin Receptor Type 2 Market
Table 40. Global Orexin Receptor Type 2 Key Players Headquarters and Area Served
Table 41. Orexin Receptor Type 2 Product Solution and Service
Table 42. Global Orexin Receptor Type 2 Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Actelion Pharmaceuticals Ltd Basic Information List
Table 45. Actelion Pharmaceuticals Ltd Description and Business Overview
Table 46. Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Products, Services and Solutions
Table 47. Revenue (US$ Million) in Orexin Receptor Type 2 Business of Actelion Pharmaceuticals Ltd (2018-2024)
Table 48. Actelion Pharmaceuticals Ltd Recent Developments
Table 49. Eisai Co Ltd Basic Information List
Table 50. Eisai Co Ltd Description and Business Overview
Table 51. Eisai Co Ltd Orexin Receptor Type 2 Products, Services and Solutions
Table 52. Revenue (US$ Million) in Orexin Receptor Type 2 Business of Eisai Co Ltd (2018-2024)
Table 53. Eisai Co Ltd Recent Developments
Table 54. Evotec AG Basic Information List
Table 55. Evotec AG Description and Business Overview
Table 56. Evotec AG Orexin Receptor Type 2 Products, Services and Solutions
Table 57. Revenue (US$ Million) in Orexin Receptor Type 2 Business of Evotec AG (2018-2024)
Table 58. Evotec AG Recent Developments
Table 59. Heptares Therapeutics Ltd Basic Information List
Table 60. Heptares Therapeutics Ltd Description and Business Overview
Table 61. Heptares Therapeutics Ltd Orexin Receptor Type 2 Products, Services and Solutions
Table 62. Revenue (US$ Million) in Orexin Receptor Type 2 Business of Heptares Therapeutics Ltd (2018-2024)
Table 63. Heptares Therapeutics Ltd Recent Developments
Table 64. Idorsia Ltd Basic Information List
Table 65. Idorsia Ltd Description and Business Overview
Table 66. Idorsia Ltd Orexin Receptor Type 2 Products, Services and Solutions
Table 67. Revenue (US$ Million) in Orexin Receptor Type 2 Business of Idorsia Ltd (2018-2024)
Table 68. Idorsia Ltd Recent Developments
Table 69. Johnson & Johnson Basic Information List
Table 70. Johnson & Johnson Description and Business Overview
Table 71. Johnson & Johnson Orexin Receptor Type 2 Products, Services and Solutions
Table 72. Revenue (US$ Million) in Orexin Receptor Type 2 Business of Johnson & Johnson (2018-2024)
Table 73. Johnson & Johnson Recent Developments
Table 74. Merck & Co Inc Basic Information List
Table 75. Merck & Co Inc Description and Business Overview
Table 76. Merck & Co Inc Orexin Receptor Type 2 Products, Services and Solutions
Table 77. Revenue (US$ Million) in Orexin Receptor Type 2 Business of Merck & Co Inc (2018-2024)
Table 78. Merck & Co Inc Recent Developments
Table 79. OptiNose US Inc Basic Information List
Table 80. OptiNose US Inc Description and Business Overview
Table 81. OptiNose US Inc Orexin Receptor Type 2 Products, Services and Solutions
Table 82. Revenue (US$ Million) in Orexin Receptor Type 2 Business of OptiNose US Inc (2018-2024)
Table 83. OptiNose US Inc Recent Developments
Table 84. Yangtze River Pharmaceutical Group Basic Information List
Table 85. Yangtze River Pharmaceutical Group Description and Business Overview
Table 86. Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Products, Services and Solutions
Table 87. Revenue (US$ Million) in Orexin Receptor Type 2 Business of Yangtze River Pharmaceutical Group (2018-2024)
Table 88. Yangtze River Pharmaceutical Group Recent Developments
Table 89. North America Orexin Receptor Type 2 Market Size by Country (2018-2024) & (US$ Million)
Table 90. North America Orexin Receptor Type 2 Market Size by Country (2024-2034) & (US$ Million)
Table 91. Europe Orexin Receptor Type 2 Market Size by Country (2018-2024) & (US$ Million)
Table 92. Europe Orexin Receptor Type 2 Market Size by Country (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Orexin Receptor Type 2 Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 94. Asia-Pacific Orexin Receptor Type 2 Market Size by Region (2018-2024) & (US$ Million)
Table 95. Asia-Pacific Orexin Receptor Type 2 Market Size by Region (2024-2034) & (US$ Million)
Table 96. Asia-Pacific Orexin Receptor Type 2 Market Share by Region (2018-2024)
Table 97. Asia-Pacific Orexin Receptor Type 2 Market Share by Region (2024-2034)
Table 98. Latin America Orexin Receptor Type 2 Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 99. Latin America Orexin Receptor Type 2 Market Size by Country (2018-2024) & (US$ Million)
Table 100. Latin America Orexin Receptor Type 2 Market Size by Country (2024-2034) & (US$ Million)
Table 101. Middle East & Africa Orexin Receptor Type 2 Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 102. Middle East & Africa Orexin Receptor Type 2 Market Size by Country (2018-2024) & (US$ Million)
Table 103. Middle East & Africa Orexin Receptor Type 2 Market Size by Country (2024-2034) & (US$ Million)
Table 104. Orexin Receptor Type 2 Market Trends
Table 105. Orexin Receptor Type 2 Market Drivers
Table 106. Orexin Receptor Type 2 Market Challenges
Table 107. Orexin Receptor Type 2 Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Orexin Receptor Type 2 Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global Orexin Receptor Type 2 Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global Orexin Receptor Type 2 Market Share by Regions: 2022 VS 2034
Figure 4. Global Orexin Receptor Type 2 Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Orexin Receptor Type 2 Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe Orexin Receptor Type 2 Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific Orexin Receptor Type 2 Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America Orexin Receptor Type 2 Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa Orexin Receptor Type 2 Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of HTL-6641
Figure 11. Global HTL-6641 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of MK-8133
Figure 13. Global MK-8133 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Product Picture of Lemborexant
Figure 15. Global Lemborexant Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 16. Product Picture of OPN-021
Figure 17. Global OPN-021 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 18. Product Picture of YNT-185
Figure 19. Global YNT-185 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 20. Product Picture of Others
Figure 21. Global Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 22. Global Orexin Receptor Type 2 Market Size Share by Type: 2022 & 2034
Figure 23. North America Orexin Receptor Type 2 Revenue Market Share by Type (2018-2034)
Figure 24. Europe Orexin Receptor Type 2 Revenue Market Share by Type (2018-2034)
Figure 25. Asia-Pacific Orexin Receptor Type 2 Revenue Market Share by Type (2018-2034)
Figure 26. Latin America Orexin Receptor Type 2 Revenue Market Share by Type (2018-2034)
Figure 27. Middle East and Africa Orexin Receptor Type 2 Revenue Market Share by Type (2018-2034)
Figure 28. Insomnia Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 29. Narcolepsy Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 30. Sleep Disorders Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 31. Major Depressive Disorder Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 32. Global Orexin Receptor Type 2 Market Size Share by Application: 2022 & 2034
Figure 33. North America Orexin Receptor Type 2 Revenue Market Share by Application (2018-2034)
Figure 34. Europe Orexin Receptor Type 2 Revenue Market Share by Application (2018-2034)
Figure 35. Asia-Pacific Orexin Receptor Type 2 Revenue Market Share by Application (2018-2034)
Figure 36. Latin America Orexin Receptor Type 2 Revenue Market Share by Application (2018-2034)
Figure 37. Middle East and Africa Orexin Receptor Type 2 Revenue Market Share by Application (2018-2034)
Figure 38. Orexin Receptor Type 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 39. Global Top 5 and Top 10 Players Orexin Receptor Type 2 Market Share in 2022
Figure 40. North America Orexin Receptor Type 2 Market Share by Country (2018-2034)
Figure 41. U.S. Orexin Receptor Type 2 Market Size (2018-2034) & (US$ Million)
Figure 42. Canada Orexin Receptor Type 2 Market Size (2018-2034) & (US$ Million)
Figure 43. Germany Orexin Receptor Type 2 Market Size (2018-2034) & (US$ Million)
Figure 44. France Orexin Receptor Type 2 Market Size (2018-2034) & (US$ Million)
Figure 45. U.K. Orexin Receptor Type 2 Market Size (2018-2034) & (US$ Million)
Figure 46. Italy Orexin Receptor Type 2 Market Size (2018-2034) & (US$ Million)
Figure 47. Russia Orexin Receptor Type 2 Market Size (2018-2034) & (US$ Million)
Figure 48. Nordic Countries Orexin Receptor Type 2 Market Size (2018-2034) & (US$ Million)
Figure 49. Asia-Pacific Orexin Receptor Type 2 Market Share by Region (2018-2034)
Figure 50. China Orexin Receptor Type 2 Market Size (2018-2034) & (US$ Million)
Figure 51. Japan Orexin Receptor Type 2 Market Size (2018-2034) & (US$ Million)
Figure 52. South Korea Orexin Receptor Type 2 Market Size (2018-2034) & (US$ Million)
Figure 53. Southeast Asia Orexin Receptor Type 2 Market Size (2018-2034) & (US$ Million)
Figure 54. India Orexin Receptor Type 2 Market Size (2018-2034) & (US$ Million)
Figure 55. Australia Orexin Receptor Type 2 Market Size (2018-2034) & (US$ Million)
Figure 56. Latin America Orexin Receptor Type 2 Market Share by Country (2018-2034)
Figure 57. Mexico Orexin Receptor Type 2 Market Size (2018-2034) & (US$ Million)
Figure 58. Brazil Orexin Receptor Type 2 Market Size (2018-2034) & (US$ Million)
Figure 59. Middle East & Africa Orexin Receptor Type 2 Market Share by Country (2018-2034)
Figure 60. Turkey Orexin Receptor Type 2 Market Size (2018-2034) & (US$ Million)
Figure 61. Saudi Arabia Orexin Receptor Type 2 Market Size (2018-2034) & (US$ Million)
Figure 62. UAE Orexin Receptor Type 2 Market Size (2018-2034) & (US$ Million)
Figure 63. Bottom-up and Top-down Approaches for This Report